Melt&Marble
Updating the operating model
- Biotechnology
- January 2026
A4BEE prepared this analysis from publicly available sources. It reflects our own reading of Melt&Marble's published strategy and is not endorsed by, or produced in cooperation with, Melt&Marble.
Strategic priorities
Melt&Marble operates across 4 stated priorities, with the most concrete near-term plan anchored on capex-light commercialization.
Scale to tens of thousands of liters and commercial volumes without building owned manufacturing facilities, relying on external CMO partners while maintaining quality control through digital connectivity.
Develop a library of designer fats (beef, chicken, palm, cocoa, shea) using proprietary yeast metabolism engineering, managing hundreds of strains with different metabolic pathways and fermentation parameters.
Validate the green premium through continuous Life Cycle Assessments, providing verifiable carbon footprint data to strategic partners Beiersdorf and Valio for their sustainability reporting.
-
01
Capex-Light Commercialization
Scale to tens of thousands of liters and commercial volumes without building owned manufacturing facilities, relying on external CMO partners while maintaining quality control through digital connectivity.
-
02
Platform Technology Expansion
Develop a library of designer fats (beef, chicken, palm, cocoa, shea) using proprietary yeast metabolism engineering, managing hundreds of strains with different metabolic pathways and fermentation parameters.
-
03
Sustainability & Decarbonization
Validate the green premium through continuous Life Cycle Assessments, providing verifiable carbon footprint data to strategic partners Beiersdorf and Valio for their sustainability reporting.
-
04
Dual-Market Regulatory Compliance
Pursue FDA GRAS for US market entry while preparing EFSA Novel Foods dossier for EU, managing two different regulatory datasets and safety arguments simultaneously.
Challenges we see
- Operations Manufacturing
Bioprocess Scale-Up Instability
The company must transition from 10-liter benchtop fermenters to 50,000+ liter commercial tanks while maintaining consistent process performance parameters such as yield and titer. In large bioreactors, hydrostatic pressure changes and mixing times increase, stressing the yeast.
Physical gradients (pH, dissolved oxygen, temperature) in large tanks cause lower fat production or off-flavors, and the R&D team in Gothenburg often has limited granular visibility into the micro-environment of cells in CMO tanks.
- Operations Manufacturing
Downstream Processing Economics
Extracting fat from yeast cells (which hold fat intracellularly) is capital and energy-intensive, requiring cell lysis and separation. This is identified as a major cost center and technical bottleneck.
If extraction efficiency drops by even 5%, unit economics collapse, making the product uncompetitive against commodity fats like palm oil. Traditional DSP runs on fixed recipes rather than dynamic feedback.
- Digital Integration
CMO Information Asymmetry
The capex-light model relies entirely on external partners for large-scale fermentation and downstream processing, creating dependency on the quality and timeliness of data transfer between Melt&Marble and their manufacturing partners.
Receiving only batch report PDFs at the end of runs rather than live granular data delays troubleshooting and creates a disconnect between strain engineers and production reality.
- Digital Operations
Fragmented R&D Data Systems
As a spinoff from academia, Melt&Marble inherited lab-scale data practices (Excel sheets, local hard drives, fragmented experiment logs). New headquarters has state-of-the-art labs but lacks a unified data backbone linking strain engineering, fermentation, and sensory results.
If a product tastes rancid, tracing back to a specific gene edit or temperature spike during fermentation takes weeks of manual data forensic work. Data scientists spend 80% of their time cleaning and formatting data rather than building models.
- Compliance Regulatory
Dual Regulatory Data Requirements
The company pursues FDA GRAS for faster US market entry while simultaneously preparing for the extremely rigorous EFSA Novel Foods process that can take up to 48 months and requires proving absence of recombinant DNA in the final product.
Managing two different datasets and safety arguments for the same product drives complexity. The EU requires specific proof of purity that the US might not emphasize, and one failed batch test that is not properly recorded can trigger regulatory halt or recall.
Opportunities, by urgency and business impact
Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.
-
Real-Time Bioprocess Visibility Gap
The R&D team in Gothenburg does not have granular visibility into the micro-environment of cells in CMO tanks during commercial-scale fermentation runs. They receive summary data after batch completion rather than live telemetry.
Implement secure data pipelines that pull live telemetry from partner PLC/SCADA systems back to Melt&Marble HQ, creating a Virtual Control Room that transforms the CMO relationship from transactional to collaborative.
-
Downstream Process Optimization
DSP runs on fixed recipes rather than dynamic feedback, leading to overuse of solvents or energy. Extraction efficiency directly impacts unit economics and competitiveness against commodity fats.
Implement Process Analytical Technology (PAT) integration with real-time sensors (Raman spectroscopy, turbidity sensors) at the DSP stage, integrated into a control loop that adjusts centrifuge speeds or solvent ratios instantly.
-
Disconnected R&D Data Silos
Insights from strain engineering (Genotype) are disconnected from fermentation performance (Phenotype) and sensory results (Product). The new HQ lacks a unified data backbone despite having state-of-the-art labs.
Implement a unified R&D data platform that links Strain Design to Fermentation to Downstream to Sensory Analysis into a single thread of data, enabling multi-parameter queries and rapid iteration.
-
Regulatory Data Governance Complexity
Managing dual regulatory pipelines (FDA GRAS and EFSA Novel Foods) with different data requirements creates manual burden. EU requires specific rDNA clearance assays tracked with higher scrutiny than US requirements.
Implement digital regulatory governance that automatically tags and segregates data based on regulatory relevance, with blockchain/immutable ledger for quality assurance linking production batches to purity test results.
-
Lack of Predictive Scale-Up Capability
The company is hiring Data Scientists for AI-driven food formulation but lacks the enterprise architecture to support them. Data scientists cannot build enterprise AI capability without underlying engineering infrastructure.
Deploy Computational Fluid Dynamics (CFD) models combined with biological data to predict how strains will behave in specific CMO tank geometry before physical runs, plus MLOps pipeline for model deployment.
What we'd propose
- Enterprise AI
CMO Digital Integration & Virtual Control Room
Establish secure, cloud-based data bridges that pull live telemetry from CMO partner PLC/SCADA systems back to Melt&Marble HQ, enabling real-time visibility into external manufacturing operations.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital CDMO
Downstream Processing PAT Integration
Implement Process Analytical Technology sensors and closed-loop control systems at the downstream processing stage to dynamically optimize extraction efficiency and reduce COGS.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
Unified R&D Data Platform
Implement a cloud-native data platform that links strain design, fermentation data, downstream processing results, and sensory analysis into a single unified thread of data for rapid iteration.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
Regulatory Data Governance Suite
Implement automated data governance systems that tag, segregate, and validate data based on dual regulatory requirements (FDA GRAS and EFSA Novel Foods) with immutable audit trails.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
Digital Twin Scale-Up Accelerator
Deploy computational fluid dynamics models combined with biological data to virtually test how yeast strains will behave in specific CMO tank geometries before committing to expensive physical production runs.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
Digital maturity: today and target
Scored out of 100 across six dimensions. The target is what Melt&Marble's own published ambition implies — not a perfect score.
- IT/OT Convergence 25 → 80
- Academic spinoff with limited connectivity to external CMO operations; needs secure data bridges to manufacturing partners
- Data Integration 30 → 85
- Fragmented Excel-based tracking and local storage; requires unified platform linking strain engineering to sensory outcomes
- Process Analytics 35 → 85
- Hiring data scientists but lacking MLOps infrastructure; needs real-time KPI calculation and predictive modeling capability
- Regulatory Compliance 40 → 90
- Manual dual-regulatory management; requires automated data governance for FDA GRAS and EFSA Novel Foods submissions
- Supply Chain Visibility 20 → 75
- Capex-light model creates control vacuum; needs centralized dashboard aggregating CMO, logistics, and raw material data
- Sustainability Reporting 35 → 80
- Manual LCA calculations; requires automated carbon footprint tracking per batch for Beiersdorf and Valio sustainability requirements
Check this yourself
Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.
-
Self-assessment
Data & AI Maturity
See how ready your data actually is for the AI work you're planning.
-
Self-assessment
Electronic Batch Record (eBR) Readiness
Check how far your batch records are from paperless, and what the next step is.
-
Market comparison
Pharma Data Platform Use Cases — Ranked
Use cases ranked by how hard they are against what they're worth.
-
Market comparison
European CDMOs Compared
The 2026 landscape: who does what, at what scale.
Think we've read this right?
Talk to usRelated reading
-
Digital Twin Maturity Model – self-assessment tool
Initially, defining what a digital twin even is seemed simple - we have a real product and its virtual counterpart, and we combine the two.
-
Still biotech or already techbio?
The results of a Tech Imperatives for biotech 2022 report indicate changes in biotech production and management.
-
OPC UA protocol support in embedded systems
OPC Unified Architecture (OPC UA) is a modern standard for data exchange, increasingly used in industrial environments.
-
From Paper to Performance: Operational Efficiency and Compliance in Labs
Transform your QC lab with scalable digital solutions that embed compliance, boost efficiency, and deliver a future-ready competitive edge.
-
Addressing sustainability in pharma & biotech
At A4BEE, we combine company social responsibility and sustainability needs with the path set by the company’s values and mission.
This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with Melt&Marble, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].